Abstract:Schiff base derivative of 2‐aminothiazole and 2,4‐dihydroxybenzaldehyde in addition to its Co (II), Cu (II), Zn (II) and Th (IV) chelates were prepared. Structure characterization of the prepared compounds by applying all available analytical and spectroscopic tools. The acquired data showed the chelation of the ligand with metal through the nitrogen of the azo group and deprotonated ortho phenolic oxygen. Investigation of antimicrobial and anticancer activity for the ligand and in addition to docking studied through interaction with 3S7S and 2JW2. For further pharmaceutical applications, a novel Schiff base derivative of aminothiazole and its Co (II), Cu (II), Zn (II), and Th (IV) chelates were designed and prepared. For this purpose, 2‐aminothiazole and 2,4‐dihydroxybenzaldehyde have been coupled before the complexation reaction with the metal salts. Elemental analysis, FT‐IR, 1HNMR, UV–Vis spectra, transmission electron microscopy (TEM), X‐ray powder diffraction (XRD), molar conductance, and magnetic moment measurements were used to determine the structural formula of the ligand and its produced chelates. The acquired data pointed out that the ligand was chelated with metal through the nitrogen of azo group and deprotonated ortho phenolic oxygen atoms. In Cu (II) complex the copper ion chelated with two ligand molecules, whereas in other complexes the metal binds with one molecule only of ligand. It was shown by XRD patterns and high‐resolution TEM images that the complex particles had a uniform distribution across the chelates' surfaces and were nanometric in size. Extremely, antimicrobial and anticancer activity for the prepared ligand and complexes were investigated, which showed high activity, especially after complex formation. Docking studies have been performed to predict the compounds' efficacy as antitumor agents through their interaction with the co‐crystal structure of proteins for breast cancer cells (PDB ID: 3S7S) and protein of liver cancer 2 (PDB ID: 2JW2). The experimental results of the anticancer activity showed promising results, especially for Cu (II) compound which exhibited the greatest antitumor efficacy (IC50 = 12.81 μg/ml) contra HepG‐2 carcinoma and Mcf‐7 cells (IC50 = 18.92 ± 0.91 μg/ml). Antimicrobial activity against the strains Klebsiella pneumoniae (K. pneumoniae), Escherichia coli (E. coli), Staphylococcus aureus (S. aureus), Bacillus subtilis (B. subtilis), C. albicans (C. albicans), and Aspergillus niger (A. niger) also gave very promising results when it is compared with the standard drugs.

Synthesis, Characterization, and Antimicrobial Evaluation of Schiff base-mixed Ligand Complexes with Divalent Metal Ions Derived from Amoxicillin and Vanillin/Nicotinamide

Synthesis of biologically active cefpodoxime and vanillin-based schiff base metal complexes with the detailed biological evaluations

Synthesis, Characterization and in vitro Biological Evaluation of a New Schiff Base Derived from Drug and its Complexes with Transition Metal Ions

Synthesis, Structural and Antimicrobial Studies of Transition Metal Complexes of a Novel Schiff Base Ligand Incorporating 1,2,4-Triazole and 4-(Benzyloxy)benzaldehyde Moieties

Synthesis, characterization, and antimicrobial activity of metal complexes derived from Schiff base of quercetin extracted from Origanum vulgare L.

Novel Mn(II) and Cu(II) metal complexes with sulfa drug-derived ligands as potent antimicrobial and anticancer agents: In vitro studies, ADMET profile and molecular docking

Manganese(II) and Zinc(II) metal complexes of novel bidentate formamide-based Schiff base ligand: synthesis, structural characterization, antioxidant, antibacterial, and in-silico molecular docking study

New Metal Complexes Incorporating Schiff Base Ligand Based on Pyridine Moiety: Synthesis, Spectral Characterization, DFT, Biological Evaluation, and Molecular Docking

Novel Co(II), Cu(II) and Fe(II) Pentadentate Schiff base complexes: Synthesis, characterization, antimicrobial, antioxidant, and molecular docking studies

Nickel(II), copper(II) and zinc(II) complexes containing symmetrical Tetradentate Schiff base ligand derived from 3,5-diiodosalicylaldehyde: Synthesis, characterization, crystal structure and antimicrobial activity

Synthesis and characterization of novel metal complexes with new azo-schiff base ligand derived from sulfa drug and toxicological studies of its complexes as antibacterial

Theoretical and experimental investigation of mixed-ligand metal(II) Schiff base complexes using maleic acid as the auxiliary ligand

Synthesis, spectroscopic characterization, density functional theory calculations and biological evaluation of novel Cu(II) and Zn(II) Schiff base complexes as antimicrobial agents

Synthesis, spectral studies and antimicrobial evaluation of transition metal complexes of bidentate Schiff base ligands derived from 4-amino quinoline

Synthesis, Characterization and Biological Efficacies from Some New Dinuclear Metal Complexes for Base 3-(3,4-Dihydroxy-phenyl)-2-[(2-hydroxy-3-methylperoxy-benzylidene)-amino]-2-methyl Propionic Acid

Metal incorporated aminothiazole-derived compounds: synthesis, density function theory analysis, in vitro antibacterial and antioxidant evaluation

Experimental and computational insights into antibacterial and antioxidant properties of metal complexes with isoniazid-based Schiff base ligands

Synthesis, characterization and antimicrobial study of polymeric transition metal complexes of Mn(II), Co(II), Ni(II), Cu(II) and Zn(II)

Efficient synthesis, characterization, and in vitro bactericidal studies of unsymmetrically substituted triazole-derived Schiff base ligand and its transition metal complexes

Synthesis, characterization, antimicrobial, molecular docking simulation, and antitumor assays of nanometric complexes based on new thiazole Schiff base derivative

New Schiff bases and their vanadium complexes: Synthesis, characterization, and biological assessment for antibacterial and antiviral action